Hologic (HOLX) – Company Press Releases
-
Bayer and Hologic Collaborating to Deliver Contrast-Enhanced Mammography
-
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2024 on Thursday, May 2, 2024
-
Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors May Be Over- or Undertreated Without Breast Cancer Index Genomic Testing
-
Hologic to Unveil Groundbreaking AI Research at ECR 2024
-
Hologic to Webcast Presentations at Upcoming Investor Conferences
-
Hologic Announces First and Only FDA-Cleared Digital Cytology System – Genius™ Digital Diagnostics System
-
Hologic Announces Financial Results for First Quarter of Fiscal 2024
-
Women's Health Remains in Crisis Worldwide Even as COVID-19 Pandemic Wanes
-
Hologic Launches ‘Better Is Possible’ Health Awareness Campaign for Women
-
Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2024
-
Hologic to Announce Financial Results for the First Quarter of Fiscal 2024 on Thursday, February 1, 2024
-
Hologic to Webcast Presentation at the 42nd Annual J.P. Morgan Healthcare Conference
-
KKR, Hologic and Ajax Health Create New Platform to Accelerate Medical Device Innovation
-
Hologic to Showcase Developments in Next-Generation AI Solutions at RSNA 2023
-
Hologic to Webcast Presentation at the 6th Annual Evercore ISI HealthCONx Conference
-
Hologic Announces Financial Results for Fourth Quarter of Fiscal 2023
-
Hologic Announces Innovative Collaboration with AAGL and Inovus Medical to Optimize OB-GYN Training for Minimally Invasive Surgeries
-
Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2023 on Thursday, November 9, 2023
-
Hologic to Expand Outreach During Breast Cancer Awareness Month
-
Nanaz Mohtashami Elected to Hologic Board of Directors
-
Hologic and Bayer Announce International Partnership to Deliver Comprehensive Contrast-Enhanced Mammography Package to Breast Imaging Facilities
-
Jennifer Meade Named President at Aldevron
-
Hologic to Webcast Presentations at Upcoming Investor Conferences
-
Hologic Announces Financial Results for Third Quarter of Fiscal 2023
-
Hologic to Announce Financial Results for the Third Quarter of Fiscal 2023 on Monday, July 31, 2023
-
Hologic Announces FDA Clearance of Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay
-
Hologic Announces Partnership with NFL Rookie Kelee Ringo and Family
-
Hologic Announces Partnership with NFL Rookie Kelee Ringo and Family
-
Hologic to Webcast Presentation at the BofA Securities 2023 Healthcare Conference
-
Hologic Announces Financial Results for Second Quarter of Fiscal 2023
-
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2023 on Monday, May 1, 2023
-
Hologic to Webcast Presentation at the Cowen 43rd Annual Health Care Conference
-
Hologic “Making a World of Difference” Through Global Sustainability Impact
-
Court of Appeals Affirms District Court Decision Invalidating Minerva Surgical Patent
-
NovaSure® V5 Global Endometrial Ablation Device Approved for Use in Canada and Europe
-
Hologic Announces Financial Results for First Quarter of Fiscal 2023
-
Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2023
-
Hologic to Announce Financial Results for the First Quarter of Fiscal 2023 on Wednesday, February 1, 2023
-
Hologic to Webcast Presentation at the 41st Annual J.P. Morgan Healthcare Conference
-
Stacey D. Stewart Elected to Hologic Board of Directors
-
New Data Presented at SABCS 2022 Reveal Expanded Predictive Value of the Breast Cancer Index™ Test for Ovarian Function Suppression in Premenopausal Women with HR+ Breast Cancer
-
Hologic Ranked #1 for Mammography System Performance and Customer Satisfaction for 10th Consecutive Year
-
Hologic to Showcase Portfolio of Comprehensive Breast and Skeletal Health Solutions at RSNA 2022
-
Hologic to Webcast Presentation at the 5th Annual Evercore ISI HealthCONx Conference
-
Hologic’s 3Dimensions™ System for 3D Mammography Receives EUREF Type Test Certification
-
Hologic Announces Contract with BARDA to Support IVD Approval of COVID Assays
-
Hologic Announces Financial Results for Fourth Quarter of Fiscal 2022
-
Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2022 on Monday, October 31, 2022
-
Hologic Rings Nasdaq Opening Bell to Kick Off Breast Cancer Awareness Month
-
More than 1.5 Billion Women Worldwide Lack Essential Health Screenings
Back to HOLX Stock Lookup
